The week in health tech, explained in plain English.Get the free newsletter →
October 28, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Provider-Sponsored Health Plans Face a Survival Test

Health systems have long chased the promise of owning their own insurance plans: capture the premium dollar, coordinate care, and control costs end to end. In 2026, that bet is looking shakier for several of them.

Renton, Wash.-based Providence is slated to close most of its insurance business, Providence Health Plan, starting in 2027, according to Becker's Hospital Review. It follows recent wind-downs by Urbana, Ill.-based Carle Health and Ann Arbor-based Michigan Medicine. The common thread is that running a health plan demands actuarial expertise, capital reserves, and enrollment scale that many providers underestimated.

Not every provider-sponsored plan is retreating, Becker's notes, and larger, well-capitalized systems continue to operate profitable insurance arms. The lesson is that vertical integration only pays off when a system can absorb insurance risk and reach enough members to spread it. For systems weighing the same move, the recent closures are a warning that the payer business rewards scale and discipline over ambition alone.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.